Demographics and Prescribed High-Risk Medications of All Women of Childbearing Age (N = 988) and the Subgroup Excluding Ondansetron (N = 383)
| Demographic and Medication | Patients on High-Risk Medication | High-Risk Subgroup Analysis |
|---|---|---|
| N (%) | N (%) | |
| Age (total population) | ||
| Less than 25 | 173 (17.5) | 30 (7.8) |
| 25 to 34 | 387 (39.2) | 108 (28.2) |
| 35 to 45 | 428 (43.3) | 245 (64.0) |
| Minority status | ||
| Yes | 593 (60.0) | 219 (57.2) |
| No | 395 (40.0) | 164 (42.8) |
| High-risk medications prescribed | ||
| Lisinopril | 195 (19.7) | 195 (50.9) |
| Topiramate | 94 (9.5) | 94 (24.5) |
| Atorvastatin | 62 (6.3) | 62 (16.2) |
| Paroxetin | 34 (3.4) | 34 (8.9) |
| Valproic acid | 33 (3.3) | 33 (8.6) |
| Simvastatin | 27 (2.7) | 27 (7.1) |
| Pravastatin | 10 (1) | 10 (2.6) |
| Ondansetron | 724 (73.3) | — |